site stats

Irinotecan dysarthria

WebJul 23, 2024 · Irinotecan is a topoisomerase-I inhibitor that is commonly used in combination with other chemotherapy agents for gastrointestinal malignancies. It has … WebJun 28, 2024 · Irinotecan-induced dysarthria has been reported in the literature, but the underlying mechanism of this neurotoxicity remains unclear. Here, we present a 35-year-old female with metastatic colon ...

National Center for Biotechnology Information

Webdysarthria while receiving intravenous infusion of irinotecan. In all our cases, dysarthria occurred during the infusion of the first course of irinotecan, and then resolved rapidly without any sequelae. Imaging of the brain was per-formed, but failed to show any evidence of an acute neurological event. We also reviewed the WebAbstract. Irinotecan (Camptosar ©, CPT-11), a topoisomerase I inhibitor, is a commonly used cytotoxic chemotherapeutic in the treatment of multiple malignancies, particularly … how does a cat drink water https://thebankbcn.com

National Center for Biotechnology Information

WebJul 26, 2024 · The patient was able to tolerate this reaction and received 20 cycles of irinotecan-based chemotherapy despite experiencing the muscle twitching with every cycle at the same onset, duration, and severity. It is possible that competitive metabolism by concomitant medications metabolized by CYP3A4 or UGT1A1 was responsible for this … WebJan 18, 2012 · In conclusion, selective irinotecan-induced dysarthria is an unusual and impressive entity, which can occur within minutes of irinotecan infusion. It is potentially related to a relative cholinergic oversensitivity of neurons in the area of the nucleus of the hypoglossal nerve. Though atropine can decrease cholinergic symptoms, it has not been ... WebNational Center for Biotechnology Information how does a cat get cancer

Irinotecan-induced central nervous system toxicity. Report on …

Category:Irinotecan-Induced Transient Dysarthria: Case Series and …

Tags:Irinotecan dysarthria

Irinotecan dysarthria

Irinotecan-Induced Transient Dysarthria: Case Series and …

WebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case series, but with limited published data aimed at understanding the underlying mechanism and effective management strategies. WebThe topoisomerase I inhibitor irinotecan is a widely used cytotoxic drug [1]. The most frequent side effects of irinotecan include acute cholinergic syn-drome (ACS), delayed-onset diarrhoea, and bone-marrow suppression [1]. Much more unusual is the occurrence of irinotecan-induced central nervous system (CNS) toxicity with dysarthria as the pre-

Irinotecan dysarthria

Did you know?

WebJul 1, 2013 · Summary A 49-year-old man with meta-static colon cancer undergoing treatment with i.v. irinotecan (180 mg/m 2 to be infused over 120 minutes) as part of a … WebBACKGROUND: Irinotecan, a topoisomerase I inhibitor, is a cytotoxic chemotherapeutic agent used to treat multiple malignancies, including those of colorectal, pancreatic, cervical, esophageal, gastric, and lung origin.Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case …

WebAug 11, 2015 · In all cases, dysarthria occurred during the infusion of irinotecan in the first course of treatment, persisted for several hours, and then resolved rapidly without any sequelae. Physical and neurological examinations at the onset of dysarthria revealed no other abnormalities. Imaging studies revealed no abnormal findings. WebMay 17, 2024 · Signs and symptoms of dysarthria vary, depending on the underlying cause and the type of dysarthria. They may include: Slurred speech. Slow speech. Inability to …

WebJan 18, 2012 · Irinotecan is a prodrug that requires in vivo activation by carboxylesterases to yield its active and potent metabolite, SN-38, which works in a cell cycle phase-specific (S phase) mechanism to...

WebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case …

WebSep 12, 2024 · Hence irinotecan may cause overstimulation of hypoglossal nerve leading to dysarthria. Oxaliplatin is known to potentiate the cholinergic effects of irinotecan by causing neuronal... how does a cat get heartwormsWebNational Center for Biotechnology Information phonophoresis ultrasound parametersWebJun 28, 2024 · Dysarthria, a state of difficult or unclear articulation of speech, has been reported as a rare side effect of irinotecan through multiple case reports and case series, … how does a cat get liver diseaseWebIrinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies Article Mar 2024 David Bing Zhen Rachel L McDevitt... how does a cat give birthWebSep 2, 2024 · Hence irinotecan may cause overstimulation of hypoglossal nerve leading to dysarthria. Oxaliplatin is known to potentiate the cholinergic effects of irinotecan by causing neuronal hyperexcitation. Hence infusion of oxaliplatin prior to irinotecan may make dysarthria more prominent. phonophoresis medication for heel spursWebSep 19, 2001 · Irinotecan (CPT-11) is a semisynthetic analogue of camptothecin with antitumor activity in solid neoplasias. Camptothecin inhibits topoisomerase I and impedes the uncoiling of the DNA double helix, thus delaying its replication and cell division. Currently, CPT-11 combined with 5-fluorouracil (5-FU) is used as a first-line treatment of advanced ... phonophorousWebJan 18, 2012 · Irinotecan is a prodrug that requires in vivo activation by carboxylesterases to yield its active and potent metabolite, SN-38, which works in a cell cycle phase-specific (S … phonophotographie